Results 191 to 200 of about 60,513 (316)
Background While treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL change.
Austin Barry+16 more
wiley +1 more source
Treatment and Survival for Unresectable Pancreatic Adenocarcinoma in Queensland, Australia, 2018-2022. [PDF]
Youlden DR+4 more
europepmc +1 more source
Objective A leading cause of death among scleroderma (SSc) patients, interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M Padilla+13 more
wiley +1 more source
Rinaldo Bellomo - An Intensive Care Medicine Icon. [PDF]
McLean A, Dobb G.
europepmc +1 more source
Objective We aimed to identify unique disease trajectories within rheumatoid arthritis‐associated interstitial lung disease (RA‐ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. Methods We performed a cohort study of RA‐ILD within the Veterans Health Administration from 1999‐2021. RA‐ILD patients were
Bryant R. England+9 more
wiley +1 more source
Changes in Patient Marker Coordinates with High-Definition Motion Management System during Frameless Gamma Knife Radiosurgery. [PDF]
Moon HC, Lee D, Park YS.
europepmc +1 more source